Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23273510)

1.

Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada.

Ogilvie GS, Cook DA, Taylor DL, Rank C, Kan L, Yu A, Mei W, van Niekerk DJ, Coldman AJ, Krajden M.

Vaccine. 2013 Feb 4;31(7):1129-33. doi: 10.1016/j.vaccine.2012.09.085. Epub 2012 Dec 25.

PMID:
23273510
2.

Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.

Rao A, Sandri MT, Sideri M, Young S, Sharma A, Behrens C.

J Clin Virol. 2013 Sep;58(1):161-7. doi: 10.1016/j.jcv.2013.06.041. Epub 2013 Jul 27.

PMID:
23895930
3.

Population-based study on the prevalence of and risk factors for human papillomavirus infection in Qujing of Yunnan province, Southwest China.

Sun LL, Jin Q, Li H, Zhou XR, Song ZQ, Cheng XM, Tao T, Liang B, Xu L, Wang YR, Zhen Y, He JW, Shen K.

Virol J. 2012 Aug 8;9:153. doi: 10.1186/1743-422X-9-153.

4.

Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.

Lindemann ML, Dominguez MJ, de Antonio JC, Sandri MT, Tricca A, Sideri M, Khiri H, Ravet S, Boyle S, Aldrich C, Halfon P.

J Mol Diagn. 2012 Jan;14(1):65-70. doi: 10.1016/j.jmoldx.2011.09.005. Epub 2011 Nov 10.

5.

Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.

Belinson JL, Hu S, Niyazi M, Pretorius RG, Wang H, Wen C, Smith JS, Li J, Taddeo FJ, Burchette RJ, Qiao YL.

Int J Cancer. 2010 Sep 1;127(5):1151-7. doi: 10.1002/ijc.25144.

PMID:
20039323
6.

Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation.

Howell-Jones R, de Silva N, Akpan M, Oakeshott P, Carder C, Coupland L, Sillis M, Mallinson H, Ellis V, Frodsham D, Robinson TI, Gill ON, Beddows S, Soldan K.

Vaccine. 2012 Jun 6;30(26):3867-75. doi: 10.1016/j.vaccine.2012.04.006. Epub 2012 Apr 16.

7.

High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology.

Geraets DT, Heideman DA, de Koning MN, Snijders PJ, van Alewijk DC, Meijer CJ, van Doorn LJ, Quint WG.

J Clin Virol. 2009 Nov;46 Suppl 3:S21-6. doi: 10.1016/S1386-6532(09)70297-5.

PMID:
20129070
8.

Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program.

Garland SM, Brotherton JM, Condon JR, McIntyre PB, Stevens MP, Smith DW, Tabrizi SN; WHINURS study group.

BMC Med. 2011 Sep 13;9:104. doi: 10.1186/1741-7015-9-104.

9.

Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.

Dalstein V, Merlin S, Bali C, Saunier M, Dachez R, Ronsin C.

J Virol Methods. 2009 Mar;156(1-2):77-83. doi: 10.1016/j.jviromet.2008.11.002. Epub 2008 Dec 17.

PMID:
19041893
10.

Automation of the linear array HPV genotyping test and its application for routine typing of human papillomaviruses in cervical specimens of women without cytological abnormalities in Switzerland.

Dobec M, Bannwart F, Kaeppeli F, Cassinotti P.

J Clin Virol. 2009 May;45(1):23-7. doi: 10.1016/j.jcv.2009.03.005. Epub 2009 Apr 16.

PMID:
19375383
11.

Evaluation of the compatibility of the Digene media when performing the Roche linear array human papillomavirus genotyping test.

Hong JH, Lee JK, Song ES, Lee JM, Kim MK.

Arch Gynecol Obstet. 2009 Oct;280(4):613-8. doi: 10.1007/s00404-009-0974-7. Epub 2009 Feb 20.

PMID:
19229548
12.

Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.

Sandri MT, Lentati P, Benini E, Dell'Orto P, Zorzino L, Carozzi FM, Maisonneuve P, Passerini R, Salvatici M, Casadio C, Boveri S, Sideri M.

J Clin Microbiol. 2006 Jun;44(6):2141-6.

13.

HPV Direct Flow CHIP: a new human papillomavirus genotyping method based on direct PCR from crude-cell extracts.

Herraez-Hernandez E, Alvarez-Perez M, Navarro-Bustos G, Esquivias J, Alonso S, Aneiros-Fernandez J, Lacruz-Pelea C, Sanchez-Aguera M, Santamaria JS, de Antonio JC, Rodriguez-Peralto JL.

J Virol Methods. 2013 Oct;193(1):9-17. doi: 10.1016/j.jviromet.2013.04.018. Epub 2013 May 13.

14.

A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years.

Giambi C, Donati S, Carozzi F, Salmaso S, Declich S, Atti ML, Ronco G, Alibrandi MP, Brezzi S, Collina N, Franchi D, Lattanzi A, Minna MC, Nannini R, Barretta E, Burroni E, Gillio-Tos A, Macallini V, Pierotti P, Bella A.

BMC Infect Dis. 2013 Feb 7;13:74. doi: 10.1186/1471-2334-13-74.

15.

Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study.

Učakar V, Poljak M, Klavs I.

Vaccine. 2012 Jan 5;30(2):116-20. doi: 10.1016/j.vaccine.2011.10.066. Epub 2011 Nov 12.

PMID:
22080175
16.

Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.

Park Y, Lee E, Choi J, Jeong S, Kim HS.

J Clin Microbiol. 2012 Jul;50(7):2359-65. doi: 10.1128/JCM.00337-12. Epub 2012 Apr 18.

17.

Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India.

Sowjanya AP, Jain M, Poli UR, Padma S, Das M, Shah KV, Rao BN, Devi RR, Gravitt PE, Ramakrishna G.

BMC Infect Dis. 2005 Dec 22;5:116.

18.

Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.

Castellsagué X, Iftner T, Roura E, Vidart JA, Kjaer SK, Bosch FX, Muñoz N, Palacios S, San Martin Rodriguez M, Serradell L, Torcel-Pagnon L, Cortes J; CLEOPATRE Spain Study Group.

J Med Virol. 2012 Jun;84(6):947-56. doi: 10.1002/jmv.23282.

PMID:
22499018
19.

Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.

Moodley JR, Constant D, Hoffman M, Salimo A, Allan B, Rybicki E, Hitzeroth I, Williamson AL.

BMC Cancer. 2009 Aug 7;9:275. doi: 10.1186/1471-2407-9-275.

20.

Can clinical tests help monitor human papillomavirus vaccine impact?

Meites E, Lin C, Unger ER, Steinau M, Patel S, Markowitz LE, Hariri S.

Int J Cancer. 2013 Sep 1;133(5):1101-6. doi: 10.1002/ijc.28115. Epub 2013 Mar 13.

PMID:
23420411
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk